Presentation is loading. Please wait.

Presentation is loading. Please wait.

Perinatal Substance Abuse Program

Similar presentations

Presentation on theme: "Perinatal Substance Abuse Program"— Presentation transcript:

1 Perinatal Substance Abuse Program
Dept of Alcohol and Drug Services (DADS) Presented by Lara Windett M.A., MFT, LPPC Certified Addiction Specialist (CAS) Please hold questions until after the presentation: I most likely will answer all questions you have as I go along…

2 The Department of Alcohol & Drug Services
exists within the overall Santa Clara Valley Health & Hospital System Dedicated to the health of the whole community regardless of ability to pay

3 Background PSAP was Brainchild of Anthony Puentes, MD, MPH, 1987
Funding stream Goal of PSAP Program The Perinatal Substance Abuse Program of SCC was introduced in 1987 to address the growing need for appropriate and effective chemical dependency treatment for pregnant women. Funding streams include:, Medical, Drug Medical, Medicare and other insurances (VHP, Valley Care), Calif State Department of Alcohol and Drug Programs, Perinatal Block Grant Funding – SAPT (Substance Abuse Prevention and Treatment) which is federal allocations for DOA Tx, Prop 36, Self Pay, State general funds. The goal of the program is to promote healthy mothers and healthy babies by providing the tools of recovery from alcohol, tobacco, and other drug addiction to mothers through treatment and education.

4 PSAP Keeps babies out of the NICU
NICU costs ~$2,100 – 5000 per day babies exposed, 30 in NICU Avg Length of Stay: 15 days Do the math (avg 3,550 per day) $1,597,500.

5 PSAP Treatment Works! 92% drug/alcohol free - neg tox screens
PSAP provides treatment for $67.15 per client per day. This diverted babies who otherwise may have been admitted to VMC’s NICU.

6 Perinatal Drug Exposure Overview
1992 Study Estimated 15-18% of pregnant women use alcohol or drugs. PSAP Admission Statistics SCC 1992 Perinatal Substance Exposure Study in California 2 hospitals participated – 9.8 % of babies born had alcohol or drugs in their systems (8 babies born per day). Women who drink alcohol/tobacco illicit drugs increase their risks for obstetrical complication and for premature labor and delivery (fetal loss, spontaneous abortion, miscarriages and stillbirths) Their addiction may result in other medical, social, legal, and family problems as they progress further in the disease of chemical dependency. On admission: 30-50% pregnant, 82% Methamphetamine users, 84% nicotine, 65% have between 1 and 3 children under 5 years of age.

7 PSAP = Empowerment Model
Comprehensive Intensive Outpatient Treatment Medically Monitored Multidisciplinary Approach Day Care for clients’ children Transportation Comprehensive Intensive Outpatient Treatment services to heroin/opiate addicted women and to women addicted to all other drugs or alcohol on and outpatient basis. Medically Monitored and supervised program. Multidisciplinary Approach to tx of chemically dependency and provide DOA as well as pregnancy, childbirth, parenting, relationship, trauma, and life skills education using SAMSHA and other guidelines Day Care for clients’ children Transportation

8 PSAP Client Eligibility
Resident of Santa Clara County Pregnant or Early Parenting Women 18 years or older On Methadone (MMT) or opiate dependent Hx or DOA abuse or currently using Family Wellness Court Referrals Medi-cal, Valley Care II, sliding scale fee, or other insurance (Kaiser) 65 Maximum clients. Pregnant women and methadone and FWC are 1st priority (holding pen to get in is discovery group).

9 Length of PSAP Stay Assigned a Licensed Therapist, PSW Case Management
Individualized Tx Plan Typical Treatment Episode: months The client is assigned a counselor who will individualize her treatment plan and corroborate with the client, our PSAP Team the legal system, and or the MD regarding the length of time required to complete the program.

10 Staff HCPM II 3 Therapists (MFT) MD Health Ed Specialist
1 Health Services Representative 3 day care aides (1/2 codes) 1 Community Worker (van) (1/2 codes) Volunteers

11 Current PSAP Client Demographics
~Capacity for 65+ Women ages 19 to 43 years 23% pregnant 10 clients on Methadone (3 pregnant) 30% Caucasian 33% Latina, 9 % Asian/Pacific Islander 18% Mixed Race 2% African American 8 % Declined to State 30% in THU’s CPS Cases ~70% Prop 36 ~40% FWC 30% Probation Only - 20% DEJ – 10%, PSAP was nominated for the 2007 National Exemplary Award for Innovative Prevention Programs, Practices and Policies by the National Association of State Alcohol/Drug Abuse Directors (NASADAD)

12 Out Patient Drug Treatment in Santa Clara County – Including Methadone
On the VMC campus Readily accessible - pregnant OPIOID DEPENDENT patients (Methadone candidates) are scheduled for admission the next business day All Patients can call Gateway Providers can call Central Valley Clinic Front Desk PSAP Clerical

13 Items to Remember if a Patient is in PSAP Treatment
We ask for a verification of OB Care/complete the referral to VMC if no care is scheduled for pregnant people. We obtain a release to speak with the OB and all MDs in the patient's life. We obtain a release to Public Health. We obtain a release to the Pedi and we alert the Pedi (and OB) if the patient drops out of treatment.

14 Overview of AOD Treatment/Concerns
Red flags When interviewing/observing the patient When considering the history Risks associated with various drugs To the pregnancy To the baby

15 Substances to Be Discussed
Opioids Cigarettes Alcohol Marijuana Methamphetamine

16 Amber 32 y.o. Woman and the mother of an 8 y.o. Unplanned pregnancy
Using daily Heroin by injection 2 grams/day Cocaine Cigarettes 2 PPD Seeking admission to methadone program

17 Amber Stealing to obtain drugs
Isolated – only living relative is maternal grandmother 8 y.o. son is being raised by patient’s grandmother Father of baby is using and at risk of deportation

18 Amber Medically indigent History of depression and anxiety
History of domestic violence (prior relationship)

19 Amber Frustrated – requested tubal ligation at 23
Frightened – concerned about damage already done to baby Motivated Requests residential treatment Resolves to leave boyfriend if he will not get into treatment

20 Red Flags: Multiple & Obvious
Patient volunteering history of substance abuse Physical exam remarkable for multiple tracks and physical withdrawal Life in disarray Chaotic and disrupted family relationships

21 Why Share this Story? Opioid dependence requires medical intervention
Pregnant patients need treatment to prevent adverse outcomes Women caring for infants need treatment to be functional mothers

22 Pregnancy can be a Huge Motivation for Change: Amber
Stabilized on methadone maintenance Completed residential treatment Permanently left the boyfriend who continued to use Delivered drug free

23 A Sense of Hope: 12 Years Later Amber is…
Abstinent and still in treatment Raising her daughter Working

24 Prevalence of AOD Abuse in Pregnancy
2008 and 2009 data from the National Survey on Drug Use and Health found that among pregnant women ages 15 to 44, the youngest ones generally reported the greatest substance use. Also, pregnant women ages 15 to 17 had similar rates of illicit drug use (15.8 percent or 14,000 women) as women of the same age who were not pregnant (13.0 percent or 832,000 women).

25 Brenda Referred to treatment for history of methamphetamine abuse
Worked as a medical assistant until about two years ago Served as caretaker for mother who died of breast cancer After mother died, dad was diagnosed with lung cancer; patient served as caretaker Reported having a prescription for vicodin

26 Brenda Reported taking prescribed vicodin for chronic back pain (occasionally) Denied history of prescription opioid abuse Weekly u tox screens consistently positive For a variety of prescription opioids Not just for vicodin Easy access to unlimited supply of prescription opioids Transferred to methadone maintenance

27 Prescription Opioid Abuse May Not Be Obvious
Consider the history Unusual number of painful conditions for a young healthy patient Multiple opioid prescriptions during pregnancy Multiple ER visits for complaints of pain Multiple care providers/no regular provider Opioids for unusual indications

28 Patient’s Appearance on Opioids
Normal Sedated with small pupils Symptoms of withdrawal Sweats/chills/gooseflesh Lacrimation/rhinorrhea Yawning/sneezing Irritable/anxious/fidgety Vomiting

29 Ask About Behaviors: Have you ever?…
Taken more than prescribed? Taken medication after the pain was gone? Gotten pills from a friend or relative? Bought pills on the street? Written or called in a prescription for yourself? Tried to stop and found you couldn’t?

30 Ask about Reasons for Use
Manage emotions? Deal with stress? Feel high? Numb everything or go to sleep?

31 Opioids: Three to Seven Times Higher Rates of…
Still birth Fetal growth retardation Low birth weight Small head circumference Prematurity Neonatal mortality

32 Heroin: Medical Risks Associated With Injection
Cellulitis Abscesses Endocarditis Hepatitis HIV infection Wound Botulism

33 Opioid Dependence in Pregnancy: Treatment
Currently, methadone maintenance is the gold standard Buprenorphine maintenance looks promising and may be more available in the future (not FDA approved) A comfortable, stable mother increases the likelihood of a healthy, term delivery

34 Impact of Methadone Treatment
Reduced deaths Reduced IVDU Reduced HIV seroconversion Reduced crime days Reduced relapse Improved health Improved relationships Improved productivity Improved social functioning 8-10 fold reduction in death rate The rule of fours Demonstrated to improve pregnancy outcome Benefits society as well as the individual drug addict

35 Additional Benefits During Pregnancy
Increased participation in prenatal care Reduced obstetrical complications Improved maternal nutrition Daily observation in clinic while dosing

36 Therapeutic Dosing With Methadone
Suppresses opioid withdrawal symptoms Reduces opioid cravings Provides a stable opioid blood level Allows a patient to concentrate on counseling/program to support recovery Minimizes side effects; patient should not be sedated

37 Methadone Withdrawal: Not Recommended During Pregnancy
The relapse rate is high (80%) Risk of intrauterine demise Risk of premature labor/miscarriage What can you say to a patient wanting to Withdraw from MMT? Send them to their primary CSLR/the addiction MD to discuss

38 Methadone Withdrawal: Not Recommended After Delivery?
Like insulin, methadone stabilizes a chronic illness The normal brain has an endogenous opioid system that may never function properly in an opioid dependent patient Very high relapse rate when methadone treatment is discontinued

39 Methadone: Effects on the Baby
No known birth defects More likely to be born at term Lower birth weight/smaller head circumference at birth May experience developmental delay during the first year of life Not associated with learning difficulties Increased SIDS with opioid exposure

40 Methadone and Breastfeeding
Negligible amounts of methadone are passed in breast milk The American Academy of Pediatrics considers methadone compatible with breastfeeding at any dose

41 Methadone: Neonatal Withdrawal
Safer than heroin withdrawal in utero Experienced by 60-80% of exposed babies Usually occurs within the first 2-3 days of life; may occur within the first month Usually treated with an opiate agonist Duration of treatment is days to months Can be life threatening without treatment

42 Opiates: The Neonatal Abstinence Syndrome
High-pitched cry, irritability Poor feeding, vomiting, diarrhea Hyper tonicity (stiff muscles) Tremors Sneezing Sweating Occasionally seizures

43 Symptoms of Opioid Withdrawal
W = wakefulness I = irritability T = tremulousness, temperature variation, tachypnea H = hyperactivity, high-pitched persistent cry, hyperacusia, hyperreflexia, hypertonus D = diarrhea, diaphoresis, disorganized suck R = rub marks, respiratory distress, rhinorrhea A = apneic attacks, autonomic dysfunction W = weight loss or failure to gain weight A = alkalosis (respiratory) L = lacrimation

44 Clarissa 23 y.o. Pregnant with first child
Smoking 1½ - 2 PPD since late teens “I will only quit if the doctor tells me my baby will die if I do not quit now” “My whole family smokes; I grew up with it; I’ve been around it my whole life”

45 United States ( ) National Household Survey on Drug Abuse (NHSDA) Survey of pregnant women Cigarettes Alcohol Any Illicit Drug % using # fetuses/yr 20.3% million 14.8% million 2.8% million Ebrahim, SH, Gfroerer, J. Pregnancy-related substance use in the United States during Obstet Gynecol 2003; 101:374.

46 Cigarette Smoking Smoking during pregnancy is the most modifiable risk factor for poor birth outcome It is associated with 5% of infant deaths, 10% of preterm births, and 30% of small for gestational age infants There are a plethora of medical risks for pregnant and non-pregnant patients Patients who smoke are more likely to relapse to other drugs of abuse Cigarettes stimulate the same brain pathway as heroin and cocaine Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), MMWR Surveill Summ May 29;58(4):1-29.

47 Cigarettes in Pregnancy: Obstetric Complications
Adverse Event Relative Risk Placental Abruption dose dependent Placenta Previa Stillbirth dose dependent Pre-term PROM Preterm Birth Low Birth Weight dose dependent

48 Clinical Outcomes in Pregnant Women who Quit Smoking
20% reduction in low birth weight babies 17% decrease in pre-term births Average increase in birth weight of 280g. Quitting before 30 weeks can still positively affect birth weight

49 Cigarette Smoking in Pregnancy & Other Drug Use
10 times higher use of marijuana 22 times higher use of cocaine 21 times higher use of amphetamine Vega, WA, Kolody, B, Hwang, J, Noble, A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993; 329:850

50 In Utero Cigarette Exposure: Congenital Malformations
May contribute to anomalies associated with focal vascular disruption Cleft lip with or without cleft palate Gastroschisis Anal atresia Transverse limb reduction defects Risk may be modified by genetic factors

51 In Utero Cigarette Exposure: Effects on the Newborn
There is a dose-response relationship between maternal cigarette use and infant… Stress Hypertonicity Excitability and irritability May be due to neurotoxicity or withdrawal With second hand smoke exposure there is an increased risk of low birth weight

52 In Utero Cigarette Exposure: Postnatal Morbidities
Morbidity Neonatal death RR SIDS RR 2.0 – 7.2 Prenatal exposure a higher risk than postnatal 2nd hand exposure Respiratory infections, asthma, otitis media, infantile colic, bronchiolitis, short stature, childhood obesity, type 2 diabetes in adulthood Heart disease and lung cancer in never smokers Second-hand smoke increases risk by 20-30%

53 In Utero Cigarette Exposure: Behavioral Problems
Toddlers (12-24 mo.s) showed a high and escalating pattern of disruptive behavior Children developed Oppositional Defiant Disorder at double the rate of controls ODD is a precursor of Conduct Disorder Seen in older children and adolescents Characterized by persistent antisocial behaviors (lying truancy, vandalism, aggression) NIDA Notes 2008: Vol.21 No. 6

54 In Utero Cigarette Exposure: Cognitive Outcomes in 9-12 yr olds
IQ impacted (dose response effect) Poorer impulse control Many individual WISC tests w/ significant dose response effects Poorer performance on tests requiring visuoperceptual skills. Auditory memory particularly impacted WISC = Wechsler Intelligence Scale for Children

55 Medical Issues for the Children of Smokers
Increased incidence of smoking initiation 20% higher if mom smoked up to 1PPD 60% higher if mom smoked 1PPD or more Diabetes mellitus Four times higher with more than 10 cigs/day Increased asthma in adult offspring Decreased sperm volume/count in adult male offspring Neonatal withdrawals are similar to opiate withdrawals less severe SIDS risk is significant…dose response curve Increased risk of asthma

56 Alcohol “Of all the substances of abuse (including cocaine, heroin, and marijuana), alcohol produces by far the most serious neurobehavioral effects in the fetus.” IOM Report to Congress, 1996

57 A look at Denial/Pre-Contemplation: Denise
28 y.o. pregnant woman and the mother of 7 and 3 y.o. boys Pregnant for the 5th time History of two 2nd trimester miscarriages Started drinking at 23 (not pregnant)

58 Denise Drinking 1-2 shots of peppermint schnapps daily until about 1 yr ago Quit drinking when learned was pregnant with second child, now age 3 GA ~ 9wks when quit Growth and development of this child appear normal

59 Denise Drinking 5 shots of peppermint schnapps daily for the past year
Drinking this pregnancy until GA ~33 wks Not worried about the baby because Last baby was okay U/S during this pregnancy looks normal

60 Alcohol Use During Pregnancy: Obstetrical Complications
Increased risk of second-trimester abortion 50% increase in fetal mortality Infant withdrawal (3-12 hrs after delivery) Fetal Alcohol Spectrum Disorders

61 Alcohol is a Teratogen that Freely Passes the Placenta
Teratogen: a substance that causes abnormal physical development Behavior teratogen: a substance that causes impaired cognitive, affective, social, reproductive, and/or sensorimotor behavior, even in the absence of obvious physical problems

62 Prenatal Alcohol Exposure Can Cause:
Death Malformation Growth deficiency Functional deficits

63 Teratogenic Effects Depend On:
Dose of alcohol Pattern of exposure (binge vs. chronic) Developmental timing of exposure Susceptibility (genotype of mother and fetus) Synergistic reactions with other drugs Interaction with nutritional variables

64 Dose-Response Effects
Higher maximum blood alcohol levels result in more severe neurotoxicity Binge drinking is particularly dangerous Males appear to be more susceptible than females

Addiction Technology Transfer Center Brookhaven Addiction Research. Center for Translational Neuroimaging National Institute of Drug Abuse (NIDA). Medical and Health Professionals Moyers On Addiction: Addiction As A Disease The Institute of Medicine. Marijuana and Medicine: Assessing the Science Base NIDA Science & Practice Perspectives National Institute of Mental Health (NIMH). Medications UCLA Addiction Clinic University of Utah. Genetic Science Learning Center Counselor Magazine for Addiction Professionals Society of Neuroscience. Advancing the Understanding of the Brain and Nervous System DADS: Please ask me for more – or me!!!

66 Content Provided by: Deborah Stephenson, MD, MPH Dept of Alcohol & Drug Services Santa Clara Valley Health & Hospital System Mark Stanford, PhD Dept of Alcohol & Drug Services Santa Clara Valley Health & Hospital System Margaret Williams, M.S., RD, H.E.S. Dept of Alcohol & Drug Services Santa Clara Valley Health & Hospital System

67 Thank you!

Download ppt "Perinatal Substance Abuse Program"

Similar presentations

Ads by Google